Analysis of Retinal Fluid and Vision Outcomes in the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) in Patients With nAMD

  • Arshad M. Khanani, MD, MA, FASRS
  • Video
  • Published 2021

See more